is mounjaro approved for prediabetes

As of now, Mounjaro (tirzepatide) is not FDA-approved for prediabetes. It is currently approved for the treatment of type 2 diabetes in adults. Mounjaro works by improving blood sugar control and has shown significant benefits in clinical trials for type 2 diabetes patients.

However, some healthcare providers may prescribe it off-label for prediabetes or weight management, depending on individual patient needs. Always consult your healthcare provider for personalized advice and treatment options.